News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Gilberto Lopes: In phase 3 EVOKE-01 study improvement of OS was noted in patients without response to prior IO
Photo generated from meetings.asco.org
Jun 3, 2024, 13:08

Gilberto Lopes: In phase 3 EVOKE-01 study improvement of OS was noted in patients without response to prior IO

Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared a post on X:

“LBA out: Phase 3 EVOKE-01 study. Sacituzumab vs Docetaxel… and… no better! Underwhelming results. One subgroup to note ‘Clinically meaningful improvement of OS was noted in patients without response to prior IO’. 383 patients OS 8.3 vs 11.8 for these patients HR 0.75 (0.58–0.97).”

Image

Read further
Source: Gilberto Lopes/X

2024 Annual Meeting of ASCO 3 EVOKE-01 ASCO24 cancer docetaxel Gilberto Lopes IO therapy LBA OncoDaily Oncology Sacituzumab
Special Coverage
Blog
Mar 29, 2025, 06:23
UICC - The Growing Global Threat of Antimicrobial Resistance in Cancer Care
Blog
Mar 29, 2025, 06:05
Yat Man Tsang: Radiation therapists’ perspectives on AI
Insight
Mar 29, 2025, 06:01
Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients
Blog
Mar 29, 2025, 04:55
Akhil Santhosh: Final overall survival results of checkmate 067 in NEJM
Blog
Mar 29, 2025, 04:16
Maximilian Merz: From student to academic physician - A 14-Year Journey at MSKCC
OncoDaily Pulse
Mar 29, 2025, 03:34
OncoDaily partners with EYOC aiming for innovation, research and equitable care
Career
Mar 29, 2025, 03:20
Nasim Eftekhari: I've been promoted to Chief AI and Analytics Officer at City of Hope
Insight
Mar 28, 2025, 20:51
Samer Al Hadidi: Check out our recent work in Blood Advances, led by Bhavesh Mohan Lal at the UAMS Myeloma Center
Blog
Mar 28, 2025, 20:17
Mustafa H. Alsaadi: Excited to share that three of our abstracts have been accepted for poster presentation at ASCO 2025
Blog
Mar 28, 2025, 20:11
Raffaele Giusti: MARIPOSA overall survival data at ELCC25
Blog
Mar 28, 2025, 19:58
Nina Niu Sanford: Here is HCC 101 video
Blog
Mar 28, 2025, 19:38
Julien Mazieres: Another brick in the wall of HER2-mutant NSCLC